Article citationsMore>>

G. Saglio, D. W. Kim, S. Issaragrisil, I. P. Coutre, G. Etienne, C. Lobo, R. Pasquini, R. E. Clark, A. Hochhaus, T. P. Hughes, N. Gallagher, A. Hoenekopp, M. Dong, A. Haque, R. A. Larson and H. M. Kantarjian, “ENESTnd Investigators. Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia,” The New England Journal of Medicine, Vol. 362, No. 24, 2010, pp. 2251-2259. doi:10.1056/NEJMoa0912614

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top